Literature DB >> 25696315

Long-term follow-up of coronary angioplasty in patients with diabetes compared with nondiabetics.

B R G Brueren, J M Ten Berg, J C Kelder, M J Suttorp, E G Mast, E Bal, S M P G Ernst, H W T Plokker.   

Abstract

BACKGROUND: Some reports have indicated that in patients with diabetes mellitus and multivessel disease, coronary artery bypass surgery is preferred over percutaneous coronary intervention (PCI). We retrospectively compared outcome PCI in diabetic and nondiabetic patients.
METHODS: Ninety-seven diabetics and 971 nondiabetics were included and randomised before PCI to aspirin alone or aspirin plus coumadin. Fifty diabetics and 481 nondiabetics underwent follow-up angiography. The primary endpoint comprised all-cause mortality, myocardial infarction or targetvessel revascularisation.
RESULTS: Baseline characteristics were similar between the groups except for significantly more males and smokers among the nondiabetics. The diabetics had significantly more previous strokes, more left anterior descending coronary artery disease as well as more restenotic lesions and multivessel disease. At 30 days, the primary endpoint had occurred in five diabetics (5.2%) and 47 nondiabetics (4.9%), (p=0.8) and at one year in 17 (17.5%) and in 165 (17.1%), respectively (p=0.9). Event-free survival remained comparable during long-term follow-up (four years). Multivariate analysis showed no differences for the occurrence of any event (p=0.9, 95% CI 0.6-1.7). At six months, the minimal luminal diameter was significantly smaller in the diabetics (1.55±0.76 mm vs. 1.78±0.66 mm, p=0.01). Diabetics also had more restenosis (41% vs. 23%, p=0.003).
CONCLUSION: Despite angiographical differences at six months between the diabetics and nondiabetics, both short-term and long-term clinical follow-up appeared to be similar.

Entities:  

Keywords:  angioplasty; diabetes mellitus; follow-up

Year:  2004        PMID: 25696315      PMCID: PMC2497095     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  16 in total

1.  Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

Authors:  A M Lincoff; R M Califf; D J Moliterno; S G Ellis; J Ducas; J H Kramer; N S Kleiman; E A Cohen; J E Booth; S K Sapp; C F Cabot; E J Topol
Journal:  N Engl J Med       Date:  1999-07-29       Impact factor: 91.245

2.  Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.

Authors:  E Van Belle; C Bauters; E Hubert; J C Bodart; K Abolmaali; T Meurice; E P McFadden; J M Lablanche; M E Bertrand
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

3.  Coronary stenting in diabetics: immediate and mid-term clinical outcome.

Authors:  T Joseph; J Fajadet; C Jordan; B Cassagneau; J C Laborde; J P Laurent; J Marco
Journal:  Catheter Cardiovasc Interv       Date:  1999-07       Impact factor: 2.692

Review 4.  Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease.

Authors:  R Kornowski; A J Lansky
Journal:  Catheter Cardiovasc Interv       Date:  2000-06       Impact factor: 2.692

5.  Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.

Authors:  B J Rensing; W R Hermans; J Vos; J G Tijssen; W Rutch; N Danchin; G R Heyndrickx; E G Mast; W Wijns; P W Serruys
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

6.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

Authors:  D L Fischman; M B Leon; D S Baim; R A Schatz; M P Savage; I Penn; K Detre; L Veltri; D Ricci; M Nobuyoshi
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

7.  Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI).

Authors:  K M Detre; P Guo; R Holubkov; R M Califf; G Sopko; R Bach; M M Brooks; M G Bourassa; R J Shemin; A D Rosen; R J Krone; R L Frye; F Feit
Journal:  Circulation       Date:  1999-02-09       Impact factor: 29.690

8.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  Can restenosis after coronary angioplasty be predicted from clinical variables?

Authors:  W S Weintraub; A S Kosinski; C L Brown; S B King
Journal:  J Am Coll Cardiol       Date:  1993-01       Impact factor: 24.094

10.  The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation.

Authors:  A Abizaid; R Kornowski; G S Mintz; M K Hong; A S Abizaid; R Mehran; A D Pichard; K M Kent; L F Satler; H Wu; J J Popma; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.